The chronic low-grade elevation in plasma concentrations of pro-inflammatory mediators (e.g. C-reactive protein (CRP) and interleukin-6 (IL-6)) is suggested to play an important role in the development of insulin resistance and atherosclerotic plaque (9, 10).